Fairvoy Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
3,257
-15
-0.5% -$5.13K 0.24% 93
2026
Q1
$1.15M Buy
3,272
+20
+0.6% +$7.13K 0.27% 87
2025
Q4
$1.06M Sell
3,252
-21
-0.6% -$6.66K 0.24% 89
2025
Q3
$924K Buy
3,273
+102
+3% +$29.6K 0.21% 96
2025
Q2
$885K Buy
3,171
+35
+1% +$9.91K 0.22% 91
2025
Q1
$977K Sell
3,136
-5
-0.2% -$1.48K 0.27% 78
2024
Q4
$819K Buy
+3,141
New +$932K 0.22% 87

Other funds holding AMGN

Fairvoy Private Wealth's AMGN Position: Q2 2026 in Review

Fairvoy Private Wealth reduced its Amgen (AMGN) stake by 0.46% in Q2 2026, selling an estimated $5.13K and leaving 3,257 shares worth $1.18M. The position accounts for 0.24% of the portfolio, ranked #93.

Fairvoy Private Wealth first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 748 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fairvoy Private Wealth held 3,257 shares of Amgen worth $1.18M as of Q2 2026.
  • Fairvoy Private Wealth sold 15 Amgen shares in Q2 2026, an estimated $5.13K.
  • Amgen made up 0.24% of Fairvoy Private Wealth's portfolio in Q2 2026, its #93 holding.
  • Fairvoy Private Wealth first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 748 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fairvoy Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.